Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 167 Carcinoma, Non-Small-Cell Lung 111 Lung Neoplasms 54 Hodgkin Disease 22 Neoplasm Metastasis 17 Recurrence 15 Lymphoma 15 Triple Negative Breast Neoplasms 14 Neoplasms 14 Prostatic Neoplasms 10 Adenocarcinoma of Lung 10 Sarcoma 9 Rhabdomyosarcoma 9 Uterine Cervical Neoplasms 8 Lymphoma, Non-Hodgkin 8 Lymphoma, Large B-Cell, Diffuse 6 Small Cell Lung Carcinoma 5 Ovarian Neoplasms 5 Mesothelioma, Malignant 5 Breast Neoplasms, Male 5 Brain Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 NSCLC 4 Multiple Myeloma 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Mesothelioma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3

Interventions

palbociclib 1 exemestane 1 delta 24-sterol reductase 1 Vinorelbine 1 Therapeutics 1 Tamoxifen 1 Standard of Care 1 Risk Assessment 1 Paclitaxel 1 Letrozole 1 Influenza Vaccines 1 Fulvestrant 1 Focus Groups 1 Epirubicin 1 Drug Therapy 1 Counseling 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Acceptance of Health Care × Vinorelbine × Clear all

NCT03355157 2024-10-01

PADMA

GBG Forschungs GmbH

Phase 4 Completed

Breast Neoplasms, Patient Acceptance of Health Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡